Exicure partners with GPCR Therapeutics for growth in biotech (NASDAQ:XCUR)

Photo of author

By [email protected]


Abstract connecting glass spheres

Schulz/E+ via Getty Images

Execure(Nasdaq:XCUR) I fell Memorandum of Understanding with GPCR Therapeutics aims to acquire GPCR USA, a subsidiary of GPCR Therapeutics, and transfer technology and collaborative research on GPCR Therapeutics’ ongoing drug development pipelines.

Through this acquisition, Exicure plans to secure



https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2148612652/image_2148612652.jpg?io=getty-c-w750

Source link

Leave a Comment